Calamos Advisors LLC Ardelyx, Inc. Transaction History

Calamos Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$5.89 - $9.31 $1.22 Million - $1.93 Million	-206,775 Reduced 94.15%	12,850 $95,000
Q1 2024 May 08, 2024	BUY	$6.05 - $9.74 $648,995 - $1.04 Million	107,272 Added 95.48%	219,625 $1.6 Million
Q4 2023 Jan 31, 2024	BUY	$3.29 - $6.64 $369,641 - $746,023	112,353 New	112,353 $696,000
Q4 2022 Jan 25, 2023	BUY	$1.22 - $2.85 $20,398 - $47,652	16,720 New	16,720 $0

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.